Arnold , the more I read VGX PR the more it sounds like a fluff PR, no mention in the PR how much cheaper it is , so if A gram is going for $250,000 dollars, they can make it for what 10% cheaper 20% cheaper ,Cytogenix said they made synDNA so they could afford doing the phase trials for herpes , is Cytogenix synDNA 75% cheaper than bacteria grown . It's still apples and oranges , Like I said if and when Cytogenix captures just 10% of the DNA vaccine market this will be a 100 dollar a share stock , and you will be very happy .
Market Data 
Markets 
AI
